References to "we", "us", "our" or the "Company" are to Valor Latitude Acquisition Corp., except where the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We were incorporated as a Cayman Islands exempted company on January 21, 2021. We were incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the "Business Combination"). While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus our search for an initial business combination on technology-enabled Latin American companies seeking to become category defining enterprises and those targeting or expected to pursue cross-border expansion.

As indicated in the accompanying unaudited condensed financial statements, as of June 30, 2022, we had $289,655 in cash and cash equivalents and deferred offering underwriter's discount of $8,050,000.

On May 6, 2021, we consummated the IPO of 20,000,000 Public Units, at a price of $10.00 per Public Unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of the IPO, we consummated the sale of 4,000,000 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, in a Private Placement to Valor Latitude LLC (the "Sponsor") and Phoenix SPAC Holdco LLC ("Phoenix"), generating gross proceeds of $6,000,000. On May 11, 2021, the underwriters purchased 3,000,000 units generating net proceeds to us of approximately $29,400,000 in the aggregate after deducting the underwriter discount.

Simultaneously with the issuance and sale of the Units on May 11, 2021, we consummated the private placement with the Sponsor and Phoenix of an aggregate of 400,000 warrants to purchase Class A Ordinary Shares for $1.50 per warrant generating total proceeds of $600,000. Of the net proceeds from the IPO, exercise of the over-allotment option, and associated private placements, $230,000,000 of cash was placed in the Trust Account. We cannot assure you that our plans to complete our Initial Business Combination will be successful.

Results of Operations

Our entire activity since inception up to June 30, 2022 relates to our formation, the Initial Public Offering and, since the closing of the Initial Public Offering, a search for a Business Combination candidate. We will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest.

For the three months ended June 30, 2022, we had a net income of $1,988,513, which included a gain from the change in fair value of warrant liabilities of $2,082,748, a gain from change in fair value of convertible note of $358 and interest income of $304,981, partially offset by a loss from operations of $399,574.



                                       23

--------------------------------------------------------------------------------

Table of Contents

For the six months ended June 30, 2022, we had a net income of $5,480,790, which included a gain from the change in fair value of warrant liabilities of $5,808,176, a gain from change in fair value of convertible note of $358 and interest income of $326,862, partially offset by a loss from operations of $654,606.

For the three months ended June 30, 2021, we had a net income of $4,201,691, which included a gain from the change in fair value of warrant liabilities of $5,270,827 and interest income of $3,011, partially offset by a loss from operations of $523,547 and transaction costs allocated to warrant liabilities of $548,600.

For the period from January 21, 2021 (inception) through June 30, 2021, we had a net income of $4,199,091, which included a gain from the change in fair value of warrant liabilities of $5,270,827 and interest income of $3,011, partially offset by a loss from operations of $526,147 and transaction costs allocated to warrant liabilities of $548,600.

Liquidity, Capital Resources and Going Concern

On May 6, 2021 we consummated our IPO and Private Placement and on May 11, 2021 the underwriters fully exercised their over-allotment option and substantially concurrently therewith, we completed the private sale of an aggregate of 400,000 additional Private Placement Warrants. Of the net proceeds from the IPO, exercise of the over-allotment option, and associated Private Placements, $230,000,000 of cash was placed in the Trust Account and $1,961,865 of cash was held outside of the Trust Account and is available for working capital purposes. Until the consummation of the IPO, our only source of liquidity was an initial purchase of ordinary shares by the Sponsor and loans from the Sponsor and a related party.

Our initial shareholders, officers, directors or their affiliates may, but are not obligated to, loan us funds as may be required ("Working Capital Loans"). If we complete a Business Combination, we may repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans, other than the interest on such proceeds that may be released for working capital purposes. Our amended and restated memorandum and articles of association provide that we will have only until May 6, 2023 to complete our initial business combination. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender's discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Warrants of the post Business Combination entity at a price of $1.50 per warrant. As of June 30, 2022, no Working Capital Loans were outstanding.

On February 28, 2022, we entered into a convertible note with the Sponsor, pursuant to which the Sponsor agreed to loan us up to an aggregate principal amount of $300,000 (the "Convertible Note"). The Convertible Note is non-interest bearing and due on the earlier of: (i) 12 months from the date thereof or (ii) the date on which we consummate a business combination. If we do not consummate a business combination, we may use a portion of any funds held outside the Trust Account to repay the Convertible Note; however, no proceeds from the Trust Account may be used for such repayment if we do not consummate the Business Combination. Up to $300,000 of the Convertible Note may be converted into warrants at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants.

At June 30, 2022, we had cash and cash equivalents outside the Trust Account of $289,655 and working capital of $237,363. Over the next 12 months, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective Initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. These conditions raise substantial doubt about our ability to continue as a going concern. Management plans to address this with the consummation of a proposed Business Combination in the combination period or with Working Capital Loans. Our Sponsor is committed and prepared to loan additional working capital to fund operations. There is no assurance that our plans to consummate a proposed business combination will occur or we will be able to borrow needed capital. As such, there is substantial doubt about our ability to continue as a going concern.



                                       24

--------------------------------------------------------------------------------

Table of Contents



In connection with the Company's assessment of going concern considerations in
accordance with Financial Accounting Standard's Board ("FASB") Accounting
Standards Update ("ASU")
2014-15,
"Disclosures of Uncertainties about an Entity's Ability to Continue as a Going
Concern," the Company has until May 6, 2023 to consummate a Business
Combination. It is uncertain that the Company will be able to consummate a
Business Combination by this time. If a Business Combination is not consummated
by this date, there will be a mandatory liquidation and subsequent dissolution
of the Company. Management has determined that the liquidity condition and
mandatory liquidation, should a Business Combination not occur, and potential
subsequent dissolution raises substantial doubt about the Company's ability to
continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate
after May 6, 2023.

Critical Accounting Policies

Use of Estimates

The preparation of our unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

We consider all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December 31, 2021, we had cash and cash equivalents amounting to $289,655 and $343,519, respectively.

Offering Costs Associated with IPO



We comply with the requirements of
ASC 34-10-S99-1 and
SEC Staff Accounting Bulletin ("SAB") Topic 5A-"Expenses of Offering". Deferred
offering costs consist of underwriting, legal, accounting and other expenses
incurred through the balance sheet date that were directly related to the IPO.
Offering costs are charged to temporary equity or the unaudited condensed
statements of operations based on the relative value of the Public Warrants to
the proceeds received from the Units sold upon the completion of the IPO.
Accordingly, on May 11, 2021 (upon the underwriters exercising their
overallotment option), offering costs totaling $13,112,968 (consisting of
$4,600,000 of underwriting fee, $8,050,000 of deferred underwriting fee and
$462,968 of other offering costs) were recognized with $548,600 which was
allocated to the Public Warrants and Private Warrants, included in the unaudited
condensed statements of operations as a component of other income/(expense) and
$12,564,368 included in temporary equity.

Fair Value of Financial Instruments

The fair value of our assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board ("FASB") ASC 820, "Fair Value Measurements and Disclosures," approximates the carrying amounts represented in the condensed balance sheets.

Convertible Promissory Note



We account for the Convertible Note under ASC 815, "Derivatives and Hedging"
("ASC 815"). Under
815-15-25,
an election can made be at the inception of a financial instrument to account
for the instrument under the fair value option under ASC 825. The Company has
made such election for its Convertible Note. Using the fair value option, the
Convertible Note is required to be recorded at its initial fair value on the
date of issuance, and each balance sheet date thereafter. Changes in the
estimated fair value of the Convertible Note is recognized as a
non-cash
gain or loss on the condensed statements of operations.

                                       25

--------------------------------------------------------------------------------

Table of Contents

Derivative Financial Instruments



We evaluate our financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded derivatives in
accordance with ASC Topic 815, "Derivatives and Hedging". Our derivative
instruments are recorded at fair value as of the IPO (May 6,
2021) and re-valued at each
reporting date, with changes in the fair value reported in the unaudited
condensed statements of operations. Derivative assets and liabilities are
classified on the condensed balance sheets as
current or non-current based on
whether
or not net-cash settlement or
conversion of the instrument could be required within 12 months of the balance
sheet date. We have determined the warrants are a derivative instrument. As the
warrants meet the definition of a derivative, the warrants are measured at fair
value at issuance and at each reporting date in accordance with ASC 820, Fair
Value Measurement, with changes in fair value recognized in the unaudited
condensed statements of operations in the period of change.

Warrant Instruments



We have accounted for the 12,066,667 warrants issued in connection with the IPO,
Private Placement, and the underwriters exercise of the over-allotment option in
accordance with the guidance contained in FASB ASC 815 "Derivatives and Hedging"
whereby under that provision the warrants do not meet the criteria for equity
treatment and must be recorded as a liability. Accordingly, we will classify the
warrant instruments as a liability at fair value and adjust the instruments to
fair value at each reporting period. This liability
will be re-measured at each
balance sheet date until the warrants are exercised or expire, and any change in
fair value will be recognized in our unaudited condensed statements of
operations. The fair value of warrants will be estimated using an internal
valuation model utilizing inputs such as assumed share prices, volatility,
discount factors and other assumptions and may not be reflective of the price at
which they can be settled. Such warrant classification is also subject
to re-evaluation at each
reporting period.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset
or paid to transfer of a liability, in an orderly transaction between market
participants at the measurement date. GAAP establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring fair value. The
hierarchy gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers
include:

     •    Level 1, defined as observable inputs such as quoted prices (unadjusted)
          for identical instruments in active markets;



     •    Level 2, defined as inputs other than quoted prices in active markets
          that are either directly or indirectly observable such as quoted prices
          for similar instruments in active markets or quoted prices for identical
          or similar instruments in markets that are not active; and



     •    Level 3, defined as unobservable inputs in which little or no market data
          exists, therefore requiring an entity to develop its own assumptions,
          such as valuations derived from valuation techniques in which one or more
          significant inputs or significant value drivers are unobservable.

Stock Based Compensation

We comply with ASC 718 Compensation - Stock Compensation regarding founder shares acquired by our directors at prices below fair value. The acquired shares shall vest upon our Company consummating an initial Business Combination (the "Vesting Date"). If prior to the Vesting Date, the director ceases to be a director, the shares will be forfeited. The founder shares owned by the director (1) may not be sold or transferred, until one year after the consummation of a business combination, (2) not be entitled to redemption from the funds held in the trust account, or any liquidating distributions. We have 24 months from the date of our initial public offering to consummate a business combination, and if a business combination is not consummated, our Company will liquidate and the shares will become worthless.



                                       26

--------------------------------------------------------------------------------

Table of Contents

Net Income Per Ordinary Share

We have two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. We have not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 12,066,667 of our Class A ordinary shares in the calculation of diluted income per share, since their exercise is contingent upon future events. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share.

Concentration of Credit Risk

Financial instruments that potentially subject us to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At June 30, 2022 and December 31, 2021, we have not experienced losses on this account and our management believes we are not exposed to significant risks on such account.

Class A Ordinary Shares Subject to Possible Redemption

We account for our ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities from Equity." Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders' equity. Our ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders' equity section of our condensed balance sheets.

Income Taxes



We account for income taxes under FASB ASC 740, "Income Taxes" ("ASC 740"). ASC
740 requires the recognition of deferred tax assets and liabilities for both the
expected impact of differences between the financial statement and tax basis of
assets and liabilities and for the expected future tax benefit to be derived
from tax loss and tax credit carry forwards. ASC 740 additionally requires a
valuation allowance to be established when it is more likely than not that all
or a portion of deferred tax assets will not be realized. ASC 740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise's
financial statements and prescribes a recognition threshold and measurement
process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. For those benefits to be
recognized, a tax position must
be more-likely-than-not to
be sustained upon examination by taxing authorities. ASC 740 also provides
guidance on derecognition, classification, interest and penalties, accounting in
interim period, disclosure and transition.

We recognize accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. We are currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. We are subject to examination since inception. We are considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, our tax provision was zero for the period presented.

Recent Accounting Standards



In May 2021, the FASB issued ASU
No. 2021-04,
Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic
470-50),
Compensation-Stock Compensation (Topic 718), and Derivatives and
Hedging-Contracts in Entity's Own Equity (Subtopic
815-40):
Issuer's Accounting for Certain Modifications or Exchanges of Freestanding
Equity-Classified Written Call Options (a consensus of the Emerging Issues Task
Force). The standard clarifies an issuer's accounting for certain modifications
or exchanges of freestanding equity-classified written call options (for
example, warrants) that remain equity classified after modification or exchange,
and it provides guidance on how an issuer would measure and recognize the effect
of these transactions. Specifically, the ASU provides a principles-based
framework to determine whether an issuer should recognize the modification or
exchange as an adjustment to equity or an expense. The amendments in this update
are effective for all entities for fiscal years beginning after December 15,
2021, including interim periods within those fiscal years. The guidance was
adopted starting January 1, 2022. Adoption of the ASU did not impact our
financial position, results of operations or cash flows.


                                       27

--------------------------------------------------------------------------------

Table of Contents

Our management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.



Off-Balance Sheet Arrangements; Commitments and
Contractual Obligations

Registration Rights Agreement

Pursuant to a registration rights agreement entered into on May 3, 2021, the holders of the Founder Shares (See Item 8, Note 5), and the Private Placement Warrants and its underlying securities (See Item 8, Note 4) are entitled to certain registration rights. We will bear the expenses incurred in connection with the filing of any registration statements pursuant to such registration rights.

Underwriting Agreement

Pursuant to the underwriting agreement, the underwriters received a cash underwriting discount of $4,600,000 following the consummation of the IPO and the exercise of the over-allotment option.

Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO and exercise of the over-allotment option, or $8,050,000, upon the completion of our Initial Business Combination subject to the terms of the underwriting agreement.

JOBS Act



The JOBS Act contains provisions that, among other things, relax certain
reporting requirements for qualifying public companies. We will qualify as an
"emerging growth company" and under the JOBS Act will be allowed to comply with
new or revised accounting pronouncements based on the effective date for private
(not publicly traded) companies. We are electing to delay the adoption of new or
revised accounting standards, and as a result, we may not comply with new or
revised accounting standards on the relevant dates on which adoption of such
standards is required
for non-emerging growth
companies. As a result, our unaudited condensed financial statements may not be
comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the
other reduced reporting requirements provided by the JOBS Act. Subject to
certain conditions set forth in the JOBS Act, if, as an "emerging growth
company," we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an independent registered public accounting firm's
attestation report on our system of internal controls over financial reporting
pursuant to Section 404, (ii) provide all of the compensation disclosure that
may be required
of non-emerging growth
public companies under the Dodd-Frank Wall Street Reform and Consumer Protection
Act, (iii) comply with any requirement that may be adopted by the PCAOB
regarding mandatory audit firm rotation or a supplement to the report of the
independent registered public accounting firm providing additional information
about the audit and the financial statements (auditor discussion and analysis),
and (iv) disclose certain executive compensation related items such as the
correlation between executive compensation and performance and comparisons of
the CEO's compensation to median employee compensation. These exemptions will
apply for a period of five years following the completion of this offering or
until we are no longer an "emerging growth company," whichever is earlier.

© Edgar Online, source Glimpses